Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STING1 | Q86WV6 | 20/20 | 0.92 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18937355 | 1.00 | STING1 (0.92) | STING1 | |
| SCHEMBL22905286 | 1.00 | STING1 (0.92) | STING1 | |
| SCHEMBL19250147 | 1.00 | STING1 (0.92) | STING1 | |
| SCHEMBL18937310 | 0.97 | STING1 (0.86) | STING1 | |
| SCHEMBL18937312 | 0.97 | STING1 (0.86) | STING1 | |
| SCHEMBL19186052 | 0.97 | STING1 (0.86) | STING1 | |
| SCHEMBL18937364 | 0.96 | STING1 (0.85) | STING1 | |
| SCHEMBL22292038 | 0.96 | STING1 (0.85) | STING1 | |
| SCHEMBL18937358 | 0.96 | STING1 (0.85) | STING1 | |
| SCHEMBL22905278 | 0.95 | STING1 (0.83) | STING1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10364266-B2 | Compounds | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2019-07-30 | — | — | US | disclosed |
| US-9718848-B2 | Compounds | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-08-01 | — | — | US | disclosed |
| US-20170158724-A1 | Novel Compounds | GLAXOSMITHKLINE INTELLECTUAL PROPERTY DEVELOPMENT LIMITED (GB) | 2017-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10364266-B2 | Compounds | STING1, IRF3, TLR9 | STING1 1/4885 |
| US-20170158724-A1 | Novel Compounds | STING1, IRF3, IFNAR1 | STING1 1/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.